New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition

Experimental and Therapeutic Medicine

Volumn 2, Issue 4, 2011, Pages 675-684

  Akbulut, Gamze ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Cachexia; Cancer; Enteral parenteral nutrition; Glutamine; N 3 fatty acids; Prebiotic probiotic oligosaccharides

Indexed keywords

GLUTAMINE; OMEGA 3 FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; CACHEXIA; CANCER PATIENT; ENTERIC FEEDING; FUNCTIONAL STATUS; GASTROINTESTINAL DISEASE; HUMAN; MALNUTRITION; NEOPLASM; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; QUALITY OF LIFE; SURVIVAL;

EID: 79958043504     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.247     Document Type: Article

References (77)

1. Jones L, Watling RM, Wilkins S and Pizer B: Nutritional support in children and young people with cancer undergoing chemotherapy. Cochrane Database Syst Rev 7: 1-50, 2010.
2. Xue H, Sawyer MB, Wischmeyer PE and Baracos VE: Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. J Parenter Enteral Nutr 35: 74-90, 2011.
3. Shike M: Nutrition therapy for the cancer patient. Hematol Oncol Clin North Am 10: 221-234, 1996.
4. Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G and Muscaritoli M: ESPEN Guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28: 445-454, 2009.
5. Morss S: Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care 23: 369-377, 2006.
6. Muscaritoli M, Bossola R, Bellantone R and Fanelli FR: Therapy of muscle wasting in cancer: what is the future? Curr Opin Clin Nutr Metab Care 7: 459-466, 2004.
7. Simons JPFHA, Schols AM, Buurman WA and Wouters EF: Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci 97: 215-223, 1999.
8. Barber MD: The pathophysiology and treatment of cancer cachexia, Nutr Clin Pract 17: 203-209, 2002.
9. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 11: 862-871, 2002.
10. Arends J: Metabolism in cancer patients. Anticancer Res 30: 1863-1868, 2010.
11. Van Cutsem E and Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9 (Suppl. 2): 51-63, 2005.
12. Jatoi A, Daly BD, Hughes VA, Dallal GE, Kehayias J and Roubenoff R: Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg 72: 348-351, 2001.
13. Argilés JM, Olivan M, Busquets S and López-Soriano FJ: Optimal management of cancer anorexia-cachexia syndrome. Cancer Manag Res 22: 27-38, 2010.
14. Nitenberg G and Raynard B: Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34: 137-168, 2000.
15. Drudge-Coates L: Improving management of patients with advanced cancer. Patient Prefer Adherence 2: 415-424, 2010.
16. Marín Caro MM, Laviano A and Pichard C: Nutritional intervention and quality of life in adult oncology patients. Clin Nutr 26: 289-301, 2007.
17. Ströhle A, Zänker K and Hahn A: Nutrition in oncology: the case of micronutrients (Review). Oncol Rep 24: 815-828, 2010.
18. Marín Caro MM, Laviano A and Pichard C: Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10: 480-487, 2007.
19. Tian J and Chen JS: Nutritional status and quality of life of the gastric cancer patients in Changle County of China. World J Gastroenterol 11: 1582-1586, 2005.
20. Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG and Lammersfeld CA: Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol 59: 704-709, 2006.
21. Ravasco P, Monteiro-Grillo I, Vidal PM and Camilo ME: Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12: 246-252, 2004.
22. Petruson KM, Silander EM and Hammerlid EB: Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 27: 302-310, 2005.
23. Bower M, Jones W, Vessels B, Scoggins C and Martin R: Role of esophageal stents in the nutrition support of patients with esophageal malignancy. Nutr Clin Pract 25: 244-249, 2010.
24. Marín Caro MM, Gómez Candela C, Castillo Rabaneda R, Lourenço Nogueira T, García Huerta M and Loria Kohen V: [Nutritional risk evaluation and establishment of nutritional support in oncology patients according to the protocol of the Spanish Nutrition and Cancer Group]. Nutr Hosp 23: 458-468, 2008.
25. Mudigonda T and Mudigonda P: Palliative cancer care ethics: principles and challenges in the Indian setting. Indian J Palliat Care 16: 107-110, 2010.
26. Maree JE and Wright SC: Palliative care: a positive outcome for cancer patients? Curationis 31: 43-49, 2008.
27. Granda-Cameron C, Viola SR, Lynch MP and Polomano RC: Measuring patient-oriented outcomes in palliative care: functionality and quality of life. Clin J Oncol Nurs 12: 65-77, 2008.
28. Wiseman M: The treatment of oral problems in the palliative patient. J Can Dent Assoc 72: 453-458, 2006.
29. Koretz RL: Should patients with cancer be offered nutritional support: Does the benefit outweigh the burden? Eur J Gastroenterol Hepatol 19: 379-382, 2007.
30. Arends J, Bodoky G, Bozzetti F, et al: ESPEN Guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 25: 245-259, 2006.
31. ASPEN Board of Directors: Clinical Guidelines Task Force, Nutrition assessment - adults. J Parenter Enteral Nutr 26: 9-12, 2002.
32. Sax HC and Souba WW: Enteral and parenteral feedings. Guidelines and recommendations. Med Clin North Am 77: 863-880, 1993.
33. Hardman WE: Omega-3 FA to augment cancer therapy. J Nutr 132 (Suppl. 11): 3508, 2002.
34. Hardman WE: N-3 fatty acids and cancer therapy. J Nutr 134 (Suppl. 12): 3427-3430, 2004.
35. Caughey GE, Mantzioris E, Gibson RA, Cleland LG and James MJ: The effect on human tumor necrosis factor alpha and interleukin 1beta production of diets enriched in or fish oil. Am J Clin Nutr 63: 116-119, 1996.
36. Barber MD: Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation. Nutrition 17: 751-755, 2001.
37. Moses AW, Slater C, Preston T, Barber MD and Fearon KC: Reduced total energy expenditure and physical activity in cachexia patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90: 996-1002, 2004.
38. Takatsuka H, Takemoto Y and Iwata N: Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 28: 769-774, 2001.
39. Bruera E, Strasser F and Palmer JL: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 21: 129-134, 2003.
40. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC and Fearon KC: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12 (Suppl. 1): 27-30, 1996.
41. Bauer JD and Capra S: Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy - a pilot study. Support Care Cancer 213: 270-274, 2005.
42. Fearon KC, von Meyenfeldt MF, Moses AG, et al: Effect of a protein and energy dense n-3 fatty acid-enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52: 1479-1486, 2003.
43. Read JA, Beale PJ, Volker DH, Smith N, Childs A and Clarke SJ: Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and infammatory status: a phase II trial. Support Care Cancer 15: 301-307, 2007.
44. Spencer L, Mann C, Metcalfe M, Webb M, Pollard C and Spencer D: The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 45: 2077-2086, 2009.
45. Fritsche KL: Are omega-3 fatty acids effective in enhancing tumoricidal cell activity? J Nutr 135: 2916-2917, 2005.
46. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ and Zandstra DF: Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 27: 84-90, 2001.
47. Berg A, Rooyackers O, Norberg A and Wernerman J: Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids 29: 221-228, 2005.
48. Darmaun D: Role of glutamine depletion in severe illness. Diabetes Nutr Metab 13: 25-30, 2000.
49. Ziegler TR, Bazargan N and Galloway JR: Glutamine enriched parenteral nutrition; saving nitrogen and saving money? Clin Nutr 19: 375-377, 2000.
50. Novak F, Heyland DK, Avenell A, Drover JW and Su X: Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30: 2022-2029, 2002.
51. Goeters C, Wenn A, Mertes N, et al: Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 30: 2032-2037, 2002.
52. Wernerman J: Clinical use of glutamine supplementation. J Nutr 138: 2040-2044, 2008.
53. Crowther M, Avenell A and Culligan DJ: Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant 44: 413-425, 2009.
54. Ziegler TR: Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy. J Nutr 131: 2578-2584, 2001.
55. Blijlevens NMA, Donnelly JP and De Pauw BE: Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25: 1269-1278, 2000.
56. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E and Rubenstein EB: The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98: 1531-1539, 2003.
57. Sonis ST, Oster G, Fuchs H, et al: Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19: 2201-2205, 2001.
58. Kuskonmaz B, Yalcin S, Kucukbayrak O, et al: The effect of glutamine supplementation on hematopoietic stem cell transplant outcome in children: a case-control study. Pediatr Transplant 12: 47-51, 2008.
59. Aquino VM, Harvey AR, Garvin JH, et al: A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 36: 611-616, 2005.
60. Ziegler TR: Glutamine supplementation in bone marrow transplantation. Br J Nutr 87 (Suppl. 1): 9-15, 2002.
61. Wilmore DW, Schloerb PR and Ziegler TR: Glutamine in the support of patients following bone marrow transplantation. Curr Opin Clin Nutr Metab Care 2: 323-327, 1999.
62. Arfons LM and Lazarus HM: Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo? Bone Marrow Transplant 36: 281-288, 2005.
63. Whelan K and Schneider SM: Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol 27: 152-159, 2011.
64. Whelan K: Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics. Proc Nutr Soc 66: 299-306, 2007.
65. De Preter V, Hamer HM, Windey K and Verbeke K: The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res 55: 46-57, 2011.
66. Pagnini C, Corleto VD, Hoang SB, Saeed R, Cominelli F and Delle Fave G: Commensal bacteria and 'oncologic surveillance': suggestions from an experimental model. J Clin Gastroenterol 42: S193-S196, 2008.
67. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT and Cominelli F: Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA 107: 454-459, 2010.
68. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R and Rowland I: Prebiotic effects: metabolic and health benefts. Br J Nutr 104 (Suppl. 2): 1-63, 2010.
69. Santacroce L, Leone D, Valenzano A, Luperto P, Bottalico L and Losacco T: Nutritional problems in the surgical patients with head and neck tumours. Literature review and personal experience. Clin Ter 156: 227-230, 2005 (In Italian).
70. Huhmann MB and August DA: Nutrition support in surgical oncology. Nutr Clin Pract 24: 520-526, 2009.
71. Huhmann MB and August DA: Review of American Society for Parenteral and Enteral Nutrition (ASPEN) clinical guidelines for nutrition support in cancer patients: nutrition screening and assessment. Nutr Clin Pract 23: 182-188, 2008.
72. Senesse P, Assenat E, Schneider S, Chargari C, Magné N and Azria D: Nutritional support during oncologic treatment of patients with gastrointestinal cancer: Who could beneft? Cancer Treat Rev 34: 568-575, 2008.
73. Arends J, Zuercher G, Dossett A, Fietkau R, Hug M and Schmid I: Non-surgical oncology - Guidelines on arenteral nutrition. Ger Med Sci 18: 1-14, 2009.
74. Pironi L, Joly F, Forbes A, et al: Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 60: 17-25, 2011.
75. Orrevall Y, Tishelman C, Herrington MK and Permert J: The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr 23: 1280-1287, 2004.
76. Braunschweig C, Liang H and Sheean P: Indications for administration of parenteral nutrition in adults. Nutr Clin Pract 19: 255-262, 2004.
77. Dy SM: Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care 23: 369-377, 2006.